Bioventus Inc. (BVS): Net Income

Annual figures by period end, from SEC filings.

$22.73M
Year ended 2025-12-31
$54.46M
Trailing 12 months to 2026-06-27
+6.7%
5-year compound annual growth
2019-12-31: $6.85M2020-12-31: $16.41M2021-12-31: $19.38M2022-12-31: -$158.70M2023-12-31: -$156.23M2024-12-31: -$36.12M2025-12-31: $22.73M$22.73M
2019-12-31 Net Income (USD) 2025-12-31
Period endedNet IncomeChange YoYSource filing
2025-12-31$22.73Mn/m2026-03-05, From 2025-01-01
2024-12-31-$36.12Mn/m2026-03-05, From 2024-01-01
2023-12-31-$156.23Mn/m2026-03-05, From 2023-01-01
2022-12-31-$158.70Mn/m2025-03-11, From 2022-01-01
2021-12-31$19.38M+18.1%2024-03-12, From 2021-01-01
2020-12-31$16.41M+139.5%2023-03-31, From 2020-01-01
2019-12-31$6.85Mn/a2022-03-11, From 2019-01-01

Net Income at similar companies

Companies with the same SEC industry code (Surgical & Medical Instruments & Apparatus), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedNet IncomeChange YoY
Bioventus Inc. (BVS)2025-12-31$22.73Mn/m
UFP Technologies Inc (UFPT)2025-12-31$68.31M+15.8%
AtriCure, Inc. (ATRC)2025-12-31-$11.45Mn/m
Glaukos Corp (GKOS)2025-12-31-$187.69Mn/m
NovoCure Ltd (NVCR)2025-12-31-$136.23Mn/m
Artivion, Inc. (AORT)2025-12-31$9.77Mn/m
iRhythm Holdings, Inc. (IRTC)2025-12-31-$44.55Mn/m
Alphatec Holdings, Inc. (ATEC)2025-12-31-$143.36Mn/m
Mimedx Group, Inc. (MDXG)2025-12-31$48.58M+14.5%

Compare BVS, UFPT, ATRC, GKOS side by side · Screen every company in Surgical & Medical Instruments & Apparatus ↗